Group-based trajectory modeling to determine long-term HIV viral load trends among children with HIV in Kenya

IF 2.9 3区 医学 Q3 IMMUNOLOGY
Jillian Neary, Irene N Njuguna, A. Wagner, Barbra A Richardson, Daisy J Chebet, Agnes Langat, E. Ngugi, Sara Benki-Nugent, Hellen Moraa, Stephen E. Hawes, J. Overbaugh, Jennifer Slyker, Dara A. Lehman, Dalton C Wamalwa, Grace John-Stewart
{"title":"Group-based trajectory modeling to determine long-term HIV viral load trends among children with HIV in Kenya","authors":"Jillian Neary, Irene N Njuguna, A. Wagner, Barbra A Richardson, Daisy J Chebet, Agnes Langat, E. Ngugi, Sara Benki-Nugent, Hellen Moraa, Stephen E. Hawes, J. Overbaugh, Jennifer Slyker, Dara A. Lehman, Dalton C Wamalwa, Grace John-Stewart","doi":"10.1097/qai.0000000000003439","DOIUrl":null,"url":null,"abstract":"\n \n Identifying determinants of longitudinal HIV viral load (VL) trajectories using group-based trajectory modeling (GBTM) can inform clinical strategies and mechanisms of non-adherence among children.\n \n \n \n Children under 12 months of age who were newly diagnosed with HIV were enrolled in the Optimizing Pediatric HIV Therapy (OPH; NCT00428116) from 2007-2010. Children initiated antiretroviral therapy (ART) at enrollment, and VL was assessed every 3 months for 24 months post-ART and 6-monthly thereafter up to 8 years of age. VL trajectory groups were defined using GBTM. Fisher’s exact and Kruskal-Wallis tests were used to determine correlates of each trajectory group compared to the sustained-low VL group.\n \n \n \n Five VL trajectory groups were identified among 89 children with 522 VL visits from 6-24 months: sustained-low VL (63% of children), sustained-very-high (16%), sustained-high (9%), low-to-high (7%), and high-with-periods-of-low (6%). Children in the sustained-high group were more frequently on a first-line protease inhibitor (PI)-based regimen (63% vs 38%; p=0.03) and had younger caregivers (median: 22 vs 28 years; p=0.02).\n Among 54 children with 560 VL visits followed from 48-96 months, 5 trajectory groups were identified: sustained-low (74%), mid-range (4%), periods-of-low (7%), high-to-low (7%), and sustained-high (7%). Those in the high-to-low group had younger caregivers (21 vs 29 years; p=0.01).\n \n \n \n GBTM identified unique VL patterns among children with unsuppressed VL. Caregiver and regimen-related characteristics were associated with patterns of non-suppression. Younger caregivers may benefit from tailored counseling to help them support child ART adherence. Palatable regimens are necessary for viral suppression among children with HIV.\n","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/qai.0000000000003439","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Identifying determinants of longitudinal HIV viral load (VL) trajectories using group-based trajectory modeling (GBTM) can inform clinical strategies and mechanisms of non-adherence among children. Children under 12 months of age who were newly diagnosed with HIV were enrolled in the Optimizing Pediatric HIV Therapy (OPH; NCT00428116) from 2007-2010. Children initiated antiretroviral therapy (ART) at enrollment, and VL was assessed every 3 months for 24 months post-ART and 6-monthly thereafter up to 8 years of age. VL trajectory groups were defined using GBTM. Fisher’s exact and Kruskal-Wallis tests were used to determine correlates of each trajectory group compared to the sustained-low VL group. Five VL trajectory groups were identified among 89 children with 522 VL visits from 6-24 months: sustained-low VL (63% of children), sustained-very-high (16%), sustained-high (9%), low-to-high (7%), and high-with-periods-of-low (6%). Children in the sustained-high group were more frequently on a first-line protease inhibitor (PI)-based regimen (63% vs 38%; p=0.03) and had younger caregivers (median: 22 vs 28 years; p=0.02). Among 54 children with 560 VL visits followed from 48-96 months, 5 trajectory groups were identified: sustained-low (74%), mid-range (4%), periods-of-low (7%), high-to-low (7%), and sustained-high (7%). Those in the high-to-low group had younger caregivers (21 vs 29 years; p=0.01). GBTM identified unique VL patterns among children with unsuppressed VL. Caregiver and regimen-related characteristics were associated with patterns of non-suppression. Younger caregivers may benefit from tailored counseling to help them support child ART adherence. Palatable regimens are necessary for viral suppression among children with HIV.
基于群体的轨迹模型确定肯尼亚感染艾滋病毒儿童的长期艾滋病毒病毒载量趋势
利用基于群体的轨迹建模(GBTM)确定HIV病毒载量(VL)纵向轨迹的决定因素,可以为临床策略和儿童不依从的机制提供信息。 2007-2010年期间,新确诊感染HIV的12个月以下儿童参加了优化儿科HIV疗法(OPH;NCT00428116)。儿童在入组时开始接受抗逆转录病毒疗法(ART),在接受抗逆转录病毒疗法后的 24 个月内,每 3 个月对 VL 进行一次评估,之后每 6 个月评估一次,直至 8 岁。VL轨迹组采用GBTM进行定义。费雪精确检验和 Kruskal-Wallis 检验用于确定各轨迹组与持续低 VL 组相比的相关性。 在 89 名 6-24 个月期间接受过 522 次 VL 检查的儿童中,确定了五个 VL 轨迹组:持续低 VL(占儿童总数的 63%)、持续极高 VL(占儿童总数的 16%)、持续高 VL(占儿童总数的 9%)、低至高 VL(占儿童总数的 7%)和高 VL 伴有低 VL 期(占儿童总数的 6%)。持续高水平组中的儿童更经常使用基于蛋白酶抑制剂 (PI) 的一线治疗方案(63% 对 38%;P=0.03),其护理人员也更年轻(中位数:22 岁对 28 岁;P=0.02)。在 54 名儿童中,有 560 人次在 48-96 个月期间接受了 VL 追踪,确定了 5 个轨迹组:持续低水平组(74%)、中水平组(4%)、低水平期组(7%)、高至低水平组(7%)和持续高水平组(7%)。从高到低组中,护理人员的年龄较小(21 岁对 29 岁;P=0.01)。 GBTM 在未抑制 VL 的儿童中发现了独特的 VL 模式。照顾者和治疗方案相关特征与未抑制模式有关。年轻的照顾者可能会受益于有针对性的咨询,以帮助他们支持儿童坚持抗逆转录病毒疗法。可口的治疗方案是艾滋病儿童病毒抑制的必要条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信